Ireland

--:--IST

Latest

Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide

Subscribe

Registers› Irish medicines ›UCB Pharma S.A.

Medicines register · Ireland

UCB Pharma S.A. — licensed medicines

42 medicines held by UCB Pharma S.A. on the Irish market, from the HPRA register.

Source: HPRA open dataset ("Authorised or Transfer Pending Products"), CC BY 4.0. Complete coverage — all 10,336 authorised products are in this register. Synced 20 Sep 2026, 17:51 UTC

Narrow the register Reset

Search within results

Matches brand name, active substance, licence holder and licence number.

Browse by first letter

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9

Medicine

Active substance

Licence holder

Status

10 mg/ml Solution for infusion EU/1/19/1383/001-002

Lacosamide

UCB Pharma S.A.

—

Bimzelx 160 mg solution for injection in pre-filled pen EU/1/21/1575/005-008

Bimekizumab

UCB Pharma S.A.

—

Bimzelx 160 mg solution for injection in pre-filled syringe EU/1/21/1575/001-004

Bimekizumab

UCB Pharma S.A.

—

Briviact 10 mg film-coated tablets EU/1/15/1073/001-004

Brivaracetam

UCB Pharma S.A.

—

Briviact 10 mg/ml oral solution EU/1/15/1073/021

Brivaracetam

UCB Pharma S.A.

—

Briviact 10 mg/ml solution for injection/infusion EU/1/15/1073/022

Brivaracetam

UCB Pharma S.A.

—

Briviact 100 mg film-coated tablets EU/1/15/1073/017-020

Brivaracetam

UCB Pharma S.A.

—

Briviact 25 mg film-coated tablets EU/1/15/1073/005-008

Brivaracetam

UCB Pharma S.A.

—

Briviact 50 mg film-coated tablets EU/1/15/1073/009-012

Brivaracetam

UCB Pharma S.A.

—

Briviact 75 mg film-coated tablets EU/1/15/1073/013-016

Brivaracetam

UCB Pharma S.A.

—

Cimzia 200 mg solution for injection in pre-filled syringe EU/1/09/544/1-2

Certolizumab pegol

UCB Pharma S.A.

—

EVENITY 105 mg solution for injection in pre-filled pen EU/1/19/1411/001-002

ROMOSOZUMAB

UCB Pharma S.A.

—

EVENITY 105 mg solution for injection in pre-filled syringe EU/1/19/1411/003-004

ROMOSOZUMAB

UCB Pharma S.A.

—

Fintepla 2.2 mg/ml oral solution EU/1/20/1491/001-004

Fenfluramine hydrochloride

UCB Pharma S.A.

—

Keppra 100 mg/ml concentrate for solution for infusion EU/1/00/146/033

Levetiracetam

UCB Pharma S.A.

—

Keppra 100 mg/ml oral solution EU/1/00/146/027

Levetiracetam

UCB Pharma S.A.

—

Keppra 1000 mg film-coated tablets EU/1/00/146/020-026

Levetiracetam

UCB Pharma S.A.

—

Keppra 250 mg film-coated tablets EU/1/00/146/001-005

Levetiracetam

UCB Pharma S.A.

—

Keppra 500 mg film-coated tablets EU/1/00/146/006-013

Levetiracetam

UCB Pharma S.A.

—

Keppra 750 mg film-coated tablets EU/1/00/146/014-019

Levetiracetam

UCB Pharma S.A.

—

KYGEVVI 2 g/2 g powder for oral solution EU/1/25/2013/001

Doxecitine, Doxribtimine

UCB Pharma S.A.

—

Lacosamide UCB 10 mg/ml Syrup EU/1/19/1383/003

Lacosamide

UCB Pharma S.A.

—

Lacosamide UCB 100 mg Film-coated tablet EU/1/19/1383/010-015

Lacosamide

UCB Pharma S.A.

—

Lacosamide UCB 150 mg Film-coated tablet EU/1/19/1383/016-021

Lacosamide

UCB Pharma S.A.

—

Lacosamide UCB 200 mg Film-coated tablet EU/1/19/1383/022-027

Lacosamide

UCB Pharma S.A.

—

Lacosamide UCB 50 mg Film-coated tablet EU/1/19/1383/004-009

Lacosamide

UCB Pharma S.A.

—

Neupro EU/1/05/331/1-3,14-20

Rotigotine

UCB Pharma S.A.

—

Neupro EU/1/05/331/38-46

Rotigotine

UCB Pharma S.A.

—

Neupro EU/1/05/331/47-55

Rotigotine

UCB Pharma S.A.

—

Rystiggo 140 mg/ml solution for injection EU/1/23/1780/001

Rozanolixizumab

UCB Pharma S.A.

—

Vimpat 10 mg/ml solution for infusion EU/1/08/470/16

Lacosamide

UCB Pharma S.A.

—

Vimpat 10 mg/ml syrup EU/1/08/470/018-019

Lacosamide

UCB Pharma S.A.

—

Vimpat 100 mg film-coated tablets EU/1/08/470/4-6

Lacosamide

UCB Pharma S.A.

—

Vimpat 15 mg/ml syrup EU/1/08/470/14-15

Lacosamide

UCB Pharma S.A.

—

Vimpat 150 mg film-coated tablets EU/1/08/470/7-9

Lacosamide

UCB Pharma S.A.

—

Vimpat 200 mg film-coated tablets EU/1/08/470/10-12

Lacosamide

UCB Pharma S.A.

—

Vimpat 50 mg film-coated tablets EU/1/08/470/1-3

Lacosamide

UCB Pharma S.A.

—

Vimpat 50mg/ 100mg/ 150mg film-coated tablets EU/1/08/470/13

Lacosamide

UCB Pharma S.A.

—

Xyrem 500 mg/mL oral solution EU/1/05/312/001

Sodium Oxybate

UCB Pharma S.A.

—

Zilbrysq 16.6 mg solution for injection in pre-filled syringe EU/1/23/1764/001-002

Zilucoplan

UCB Pharma S.A.

—

Zilbrysq 23 mg solution for injection in pre-filled syringe EU/1/23/1764/003-004

Zilucoplan

UCB Pharma S.A.

—

Zilbrysq 32.4 mg solution for injection in pre-filled syringe EU/1/23/1764/005-006

Zilucoplan

UCB Pharma S.A.

—

Cite this view

Priya Life Science (2026). Irish Medicines Register, filtered. Derived from the HPRA open dataset. Retrieved 3 October 2026. https://priyalifescience.com/medicines/company/ucb-pharma-s-a

Download this register

GET /api/export.php?register=medicines-ie&format=csv Try the JSON export →

Regulatory information only — not medical advice. For the authoritative record see the HPRA register directly.